register

News & Trends - MedTech & Diagnostics

Philips partners for world-first research to reduce patient anxiety during MRI scans

Health Industry Hub | March 5, 2021 |

MedTech News: Philips, a global leader in health technology, is teaming up to test the effects of custom-made animation within Philips Ambient Experience, to reduce fear and anxiety during MRI scans.

Philips’ clinical research project with The Walt Disney Company will commence in Europe and the results of the pilot project will be completed later this year. It is the first time Disney has collaborated as part of a clinical research project of this kind.

Philips will investigate how Philips Ambient Experience – using a series of animated stories, including some of Disney’s most beloved characters  – can improve the patient and clinician experience during paediatric MRI procedures.

Medical exams like MRI scans can be challenging for many patients, especially children, who are anxious or claustrophobic. Philips Ambient Experience – with 2,000 installations worldwide – helps manage these challenges by creating an engaging, multi-sensorial imaging environment that is welcoming and relaxing to help improve efficiency with higher patient throughput and predictability, significantly reducing the need for retakes and rescans.

International Women's Day 2021 - Health Industry Hub
Interview links will be provided on 8th March.

“A visit to the hospital can be quite intimidating for people, and especially children, where a more patient-friendly, patient-centric environment could help improve the patient experience and help drive first-time-right imaging for improved outcomes,” said Kees Wesdorp, Chief Business Leader of Precision Diagnosis at Philips.

“With this pilot study, we will investigate the impact of Philips Ambient Experience including Disney’s specially developed themes to empower children with a positive experience to help them throughout the medical procedure. Philips has always taken a human-centric approach to healthcare. Together, we can make a real difference for thousands of young patients going through medical procedures each day,” he added.

“I have seen first-hand that MRI scans can be intimidating for children, and I like how focused Philips is on the patient experience,” said Jan Koeppen, President, the Walt Disney Company, EMEA. “At Disney, we look forward to complementing Philips’ MRI experience with our stories and characters. We are excited to see the results of the clinical research and to quantify the impact our characters can have in this environment.”

Philips is showcasing its Ambient Experience solution at the European Congress of Radiology virtual event, March 3-7, 2021.


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


News & Trends - MedTech & Diagnostics

Federal government invests in Siemens Healthineers scanner to 'reduce wait times' for cancer diagnosis

Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]

More


News & Trends - MedTech & Diagnostics

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]

More


News & Trends - Biotechnology

CSL's world-first gene therapy heads for MSAC assessment

CSL’s world-first gene therapy heads for MSAC evaluation

Health Industry Hub | April 23, 2024 |

Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]

More


This content is copyright protected. Please subscribe to gain access.